COVID-19 Vaccine Access Uproar Underscores Importance Of At-Risk Manufacturing

 
• By Kevin Grogan

Sanofi CEO Hudson tries to reassure France on access, but notes that Europe does not currently have a program to assure a supply of a coronavirus vaccine as soon as safety and efficacy have been established.

Pile of Money on Fire
Trying to assure the biggest supply of vaccine as soon as possible may mean burning money by making large amounts of the product even before it's been proven to work.

More from Vaccines

More from Pink Sheet